Health Condition 1: L810- Postinflammatory hyperpigmentation
Conditions
Interventions
None listed
Sponsors
Ms Ozone Pharmaceuticals Ltd
Eligibility
Inclusion criteria
Inclusion criteria: Patients of either sex having mild to moderate facial Acne and mild to moderate acne induced PIH in clinical features. ïâ??· Patients of age between 18 - 45 years. ïâ??· Willing to take part in study and signing consent form
Exclusion criteria
Exclusion criteria: 1. With Present History of Skin Disease e.g. Psoriasis, Dermatitis, Vitiligo etc. related to face. 2. Person suffering from any infective or contagious skin disease 3. Under medication with antibiotics, antifungal and steroid during last one month. 4. Women on Oral contraceptives 5. Patients of known uncontrolled hormonal disease. 6. Any kind of diagnosed hereditary skin disorder. 7. Patient who had undergone any type of skin treatment like laser therapy in last 6 months
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary endpoint ââ?¬â?? Changes from baseline to the end of trial period in ïâ??· Individual lesion count and overall lesion count in Acne ïâ??· Overall grading of Acne in Investigatorââ?¬â?¢s Global Assessment scale for Acne Timepoint: baseline, 4 weeks and 8 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary Endpoint ïâ??· ââ?¬â??Changes from baseline to the end of trial period in Acne induced Post inflammatory hyperpigmentation severity scale Safety/Tolerability Endpoints ïâ??· No visible Erythema, oedema, , scaling, dryness, burning, tingling stinging & itching ïâ??· Monitoring of adverse events throughout the course of the studyTimepoint: baseline, 4 weeks and 8 weeks | — |
Countries
India
Contacts
Public ContactSumit Nathani
National Institute of Ayurveda
Outcome results
None listed